This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Domestic Production Of Medical Isotope Mo-99 Moves A Step Closer At Los Alamos

LOS ALAMOS, N.M., May 13, 2013 /PRNewswire-USNewswire/ -- Today, Los Alamos National Laboratory announced that for the first time, irradiated uranium fuel has been recycled and reused for molybdenum-99 (Mo-99) production, with virtually no losses in Mo-99 yields or uranium recovery. This demonstrates the viability of the separation process, as well as the potential for environmentally- and cost-friendly fuel recycling. Medical isotope production technology has advanced significantly now that scientists have made key advances in separating Mo-99 from an irradiated, low-enriched uranium (LEU) solution.

(Photo: http://photos.prnewswire.com/prnh/20130513/DC13213 )

Low-Enriched Uranium as a Source of Mo-99

Technetium-99m (Tc-99m) is the most commonly used medical isotope today, accounting for about 50,000 medical imaging procedures daily in the United States. Tc-99m is derived from the parent isotope Mo-99, predominantly produced from the fission of uranium-235 in highly enriched uranium targets (HEU) in aging foreign reactors. The North American supply of Tc-99m was severely disrupted when the Chalk River nuclear reactor in Canada experienced an outage several years ago.

The National Nuclear Security Administration's Global Threat Reduction Initiative (GTRI) implements the long-standing U.S. policy to minimize and eliminate the use of HEU in civilian applications.  In support of this objective, GTRI is working with U.S. commercial entities and the U.S. national laboratories to develop a diverse set of non-HEU-based technologies to produce Mo-99 in the United States. 

The U.S. national laboratories aid GTRI's programmatic mission by conducting research and development, engineering and design support, and proof of concept demonstrations. Toward this goal, GTRI has been working with Los Alamos to ensure its technical expertise is available to support GTRI's commercial partners, including Morgridge Institute for Research-SHINE Medical Technologies (MIR-SHINE), which proposes to use a particle accelerator to produce Mo-99 from a mildly acidic LEU solution.

The Technical Demonstration

In support of MIR-SHINE's Mo-99 production efforts, researchers at Los Alamos have successfully proven the technical viability of the initial stage of Mo-99 recovery from LEU solution through a direct scaled-down demonstration of the proposed industrial process.

To undertake the necessary experimental validation, Los Alamos researchers developed methodologies for preparing and analyzing uranium sulfate fuel, safely containing the fuel during irradiation at a Los Alamos Neutron Accelerator Science (LANSCE) facility and performing chemical flow-sheet testing using a separation apparatus applicable to both low and high levels of radiation.

With a short half-life of 2.7 days, Mo-99 is a high specific-radioactivity isotope. At production scale, the post-fission solution will contain only a very small concentration of Mo-99. Unlike traditional HEU-based processes, the challenge is to recover this material from a vast excess of LEU and leave the uranium in the same chemical form to allow for recycling.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,584.40 -30.41 -0.18%
S&P 500 1,946.15 +4.87 0.25%
NASDAQ 4,423.8870 +4.4090 0.10%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs